Eine unerwünschte Wirkung von Methadon und Moxifloxacin [PDF]
Crettol, S. +5 more
core +1 more source
Applicability domain-expansion studies for machine learning models reveal new inhibitors of CYP2B6. [PDF]
Vignaux PA +3 more
europepmc +1 more source
Identification of CYP2B6 as a Novel Biomarker of HRD in Colon Adenocarcinoma through WGCNA and Machine Learning. [PDF]
Gao X, Yao J, Hu Q, Yu C, Yang Y.
europepmc +1 more source
Japanese genomes for pharmacogenomics: primary and secondary pipelines for population-specific insights. [PDF]
Crawford CW +6 more
europepmc +1 more source
Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]
Dybowska D, Pawłowska M, Kozielewicz D.
europepmc +1 more source
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis. [PDF]
Sharafshah A +13 more
europepmc +1 more source
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins [PDF]
H. H. J. Gerets +6 more
core +1 more source
Expression and function of CYP enzymes and hepatobiliary transporters in an improved long-term sandwich culture hepatocyte model. [PDF]
Pacsuta J +6 more
europepmc +1 more source
Dual-Biosensor for Five Drugs Detection in Precision Oncology. [PDF]
Rodino F +4 more
europepmc +1 more source
CYP2B6*6 single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: Implications on efficacy of artemether-lumefantrine. [PDF]
Angwe MK +8 more
europepmc +1 more source

